Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
1-15 of 437
Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Project Oncology®Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies
Steve Jackson, PharmD
Paolo F. Caimi, MD
Narendranath Epperla, MD, MS
Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
Project Oncology®Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Project Oncology®From Durability to Discovery: Advances in ALK+ mNSCLC Treatment
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Project Oncology®How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Angel Qin, MD
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Project Oncology®How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
Patterns of Progression and Resistance in ALK+ mNSCLC
Project Oncology®Patterns of Progression and Resistance in ALK+ mNSCLC
Alice T. Shaw, MD, PhD
- advertisement
Guiding mNSCLC Treatment After ALK-TKI Progression
Project Oncology®Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Project Oncology®Investigating Unanswered Questions in ALK+ mNSCLC Care
Alice T. Shaw, MD, PhD
Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Project Oncology®Comparing CAR T-Cell Therapies for R/R Multiple Myeloma
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Project Oncology®CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Project Oncology®Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Project Oncology®A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
- advertisement
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD